Open AccessCancer incidence and mortality following treatment of hyperthyroidism with radioactive iodine
Author(s) -
Josh M Evron,
Nazanene H. Esfandiari,
Maria Papaleontiou
Publication year - 2020
Publication title -
current opinion in endocrinology, diabetes and obesity./current opinion in endocrinology, diabetes and obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.199
H-Index - 67
eISSN - 1752-2978
pISSN - 1752-296X
DOI - 10.1097/med.0000000000000561
Subject(s) - radioactive iodine , incidence (geometry) , medicine , thyroid cancer , iodine , cancer , oncology , radiochemistry , pediatrics , nuclear medicine , thyroid , chemistry , physics , organic chemistry , optics
Hyperthyroidism is a commonly encountered clinical issue. Radioactive iodine is one of the treatment modalities employed over the last 80 years. Prior studies are conflicting as to whether radioactive iodine is associated with an increased risk of subsequent malignancy and associated mortality. The present article reviews recent publications on this subject.